Thrombin Inhibition Reduces the Expression of Brain Inflammation Markers upon Systemic LPS Treatment

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Gene</td><td class="align_center">Forward</td><td class="align_center">Reverse</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">HPRT</td><td class="align_center">GATTAGCGATGATGAACCAGGTT</td><td class="align_center">CCTCCCATCTCCTTCATGA CA</td></tr><tr><td class="align_left">PT (prothrombin)</td><td class="align_center">CCGAAAGGGCAACCTAGAGC</td><td class="align_center">GGCCCAGAACACGTCTGTG</td></tr><tr><td class="align_left">FX (factor X)</td><td class="align_center">GTGGCCGGGAATGCAA</td><td class="align_center">AACCCTTCATTGTCTTCGTTAATGA</td></tr><tr><td class="align_left">PAR1</td><td class="align_center">TGAACCCCCGCTC ATTCTTTC</td><td class="align_center">TGAACCCCCGCTC ATTCTTTC</td></tr><tr><td class="align_left">EPCR</td><td class="align_center">ATGTGGCCGTGAATGGAAGCGC</td><td class="align_center">CCATCAGGATGCCCAGGACC</td></tr><tr><td class="align_left">TNF<i>α</i></td><td class="align_center">GACCCTCACACTCAGATCATCTTCT</td><td class="align_center">CCTCCACTTGGTGGTTTGCT</td></tr><tr><td class="align_left">IL1<i>β</i></td><td class="align_center">CTGGTGTGTGACGTTCCCATTA</td><td class="align_center">CCGACAGCACGAGGCTTT</td></tr><tr><td class="align_left">CCL2</td><td class="align_center">CCGGCTGGAGCATCCACGTGT</td><td class="align_center">TGGGGTCAGCACAGACCTCTCTCT</td></tr><tr><td class="align_left">CXL9</td><td class="align_center">TCCTTTTGGGCATCATCTTCC</td><td class="align_center">TTTGTAGTGGATCGTGCCTCG</td></tr><tr><td class="align_left">CCL1</td><td class="align_center">CACAGGGGCGCCTATCGCCAA</td><td class="align_center">CAAGGCAAGCCTCGCGACCAT</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Neural Plasticity

tab1

Table 1

Table 1: Thrombin Inhibition Reduces the Expression of Brain Inflammation Markers upon Systemic LPS Treatment 